HomeARWR • NASDAQ
Arrowhead Pharmaceuticals Inc
$12.69
3.97%
+0.48 Today
After Hours:
$12.11
(4.57%)-0.58
Closed: Apr 2, 7:33:51 PM UTC-4 · USD · NASDAQ · Disclaimer
Market news
Financials
Income Statement
-150M-100M-50M0
Revenue
Net Income
Revenue
Net income
(USD)Dec 2024Y/Y change
Revenue
2.50M-29.60%
Operating expense
163.91M17.00%
Net income
-173.09M-30.27%
Net profit margin
-6.92K-85.04%
Earnings per share
-1.39-12.10%
EBITDA
-156.18M-18.06%
Effective tax rate
-0.06%
0500M1B
Total Assets
Total Liabilities
Total assets
Total liabilities
(USD)Dec 2024Y/Y change
Cash and short-term investments
550.84M158.15%
Total assets
1.01B61.86%
Total liabilities
957.62M111.59%
Total equity
56.08M
Shares outstanding
126.10M
Price to book
29.06
Return on assets
-37.48%
Return on capital
-40.94%
-50M050M
Net Change in Cash
Net change in cash
(USD)Dec 2024Y/Y change
Net income
-173.09M-30.27%
Cash from operations
-146.27M-24.13%
Cash from investing
76.91M18.62%
Cash from financing
20.63M7,628.09%
Net change in cash
-48.80M7.37%
Free cash flow
-114.43M33.38%
StockUS listed securityUS headquartered
Previous close
$12.21
Day range
$11.89 - $12.84
Year range
$11.89 - $30.41
Market cap
1.74B USD
Avg Volume
1.59M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Arrowhead Pharmaceuticals, Inc. is a publicly traded biopharmaceutical company based in Pasadena, California. Arrowhead’s products in development act through RNA interference mechanisms of action. The company focuses on treatments for hepatitis B, liver disease associated with alpha 1-antitrypsin deficiency and cardiovascular disease. Wikipedia
Founded
Jan 1, 2004
Employees
609
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Main menu
Google apps